Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 11/Signature 1

From BugSigDB
Reviewed Marked as Reviewed by Peace Sandy on 2024-4-9

Curated date: 2024/03/17

Curator: FaithAlexander

Revision editor(s): FaithAlexander

Source: Table 2 and Text

Description: 16S rRNA analysis showing the differences in the relative abundance of microbiota composition between Parkinson's disease Patients treated with entacapone and Healthy Controls.

Abundance in Group 1: increased abundance in Parkinson's disease Patients treated with entacapone

NCBI Quality ControlLinks
Anaerococcus
Bifidobacteriaceae
Bifidobacterium
Enterococcaceae
Enterococcus
Peptoniphilus
Peptostreptococcaceae
Sellimonas
[Eubacterium] brachy

Revision editor(s): FaithAlexander